|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
WO2001028519A1
(de)
*
|
1999-10-20 |
2001-04-26 |
Vesifact Ag |
Mikroemulsion-prekonzentrate und mikroemulsionen
|
|
CN1951899B
(zh)
|
2000-02-16 |
2012-02-01 |
布里格姆及妇女医院股份有限公司 |
阿司匹林触发的脂质介体
|
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
|
SE0000773D0
(sv)
*
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
|
US6596306B1
(en)
*
|
2000-07-07 |
2003-07-22 |
David Ho Sue San Ho |
Drug delivery system:formulation for fat-soluble drugs
|
|
MY120392A
(en)
*
|
2000-06-08 |
2005-10-31 |
Hovid Berhad |
A novel drug delivery system : formulation for fat-soluble drugs
|
|
WO2002030414A1
(en)
*
|
2000-10-11 |
2002-04-18 |
Cephalon, Inc. |
Compositions comprising modafinil compounds
|
|
FR2818905A1
(fr)
*
|
2000-12-28 |
2002-07-05 |
Cll Pharma |
Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
|
|
ATE381923T1
(de)
*
|
2001-02-11 |
2008-01-15 |
Aquanova Ag |
Verfahren zur herstellung eines wirkstoffkonzentrats sowie wirkstoffkonzentrat
|
|
WO2002064109A2
(en)
*
|
2001-02-14 |
2002-08-22 |
Gw Pharma Limited |
Mucoadhesive pharmaceutical formulations
|
|
ATE258427T1
(de)
*
|
2001-04-12 |
2004-02-15 |
Vesifact Ag |
Pharmazeutische formulierungen enthaltend entzündungshemmende wirkstoffe und deren verwendung
|
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
|
WO2003053423A2
(en)
|
2001-12-18 |
2003-07-03 |
The Brigham And Women's Hospital |
Inhibition or prevention of infection by bacteria with epa, dha or analogs
|
|
KR100441167B1
(ko)
*
|
2001-12-27 |
2004-07-21 |
씨제이 주식회사 |
마이크로에멀젼 예비 농축액 조성물
|
|
US7582785B2
(en)
|
2002-04-01 |
2009-09-01 |
University Of Southern California |
Trihydroxy polyunsaturated eicosanoid derivatives
|
|
DK1553940T3
(da)
|
2002-07-30 |
2008-06-02 |
Wyeth Corp |
Patenterale formuleringer indeholdende en rapamycin-hydroxyester
|
|
US7759395B2
(en)
|
2002-08-12 |
2010-07-20 |
The Brigham And Women's Hospital, Inc. |
Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
|
|
ATE449057T1
(de)
|
2002-08-12 |
2009-12-15 |
Brigham & Womens Hospital |
Resolvine: biotemplate zur durchführung therapeutischer anwendungen
|
|
CA2504329C
(en)
|
2002-11-01 |
2013-08-20 |
Biodelivery Sciences International, Inc. |
Geodate delivery vehicles
|
|
US7842791B2
(en)
|
2002-12-19 |
2010-11-30 |
Nancy Jean Britten |
Dispersible pharmaceutical compositions
|
|
US20040185068A1
(en)
*
|
2003-03-18 |
2004-09-23 |
Zhi-Jian Yu |
Self-emulsifying compositions, methods of use and preparation
|
|
US7879345B2
(en)
|
2003-04-11 |
2011-02-01 |
L'oreal |
Composition containing an amphiphilic polymer, uses thereof
|
|
FR2853527B1
(fr)
*
|
2003-04-11 |
2006-06-23 |
Oreal |
Composition sous forme d'une emulsion huile-dans-eau contenant un polymere amphiphile, et ses utilisations notamment cosmetiques
|
|
WO2005087194A1
(en)
*
|
2004-03-10 |
2005-09-22 |
Schering Aktiengesellschaft |
Compositions comprising drospirenone molecularly dispersed
|
|
US20080249147A1
(en)
*
|
2004-03-24 |
2008-10-09 |
Takeda Pharmaceutical Company Limited |
Emulsion-Stabilized Preparation
|
|
US20050232974A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Gore Makarand P |
System and a method for pharmaceutical dosage preparation using jettable microemulsions
|
|
US20090149533A1
(en)
*
|
2004-08-06 |
2009-06-11 |
Transform Pharmaceuticals, Inc. |
Novel fenofibrate formulations and related methods of treatment
|
|
CN100361656C
(zh)
|
2004-08-27 |
2008-01-16 |
石药集团中奇制药技术（石家庄）有限公司 |
丁苯酞自乳化释药体系及其制备方法和应用
|
|
GT200500310A
(es)
|
2004-11-19 |
2006-06-19 |
|
Compuestos organicos
|
|
CA2618974C
(en)
*
|
2005-08-09 |
2014-01-28 |
Nanobio Corporation |
Nanoemulsion compositions having anti-inflammatory activity
|
|
US8273792B2
(en)
|
2005-10-03 |
2012-09-25 |
The Brigham And Women's Hospital, Inc. |
Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers
|
|
WO2014160989A2
(en)
|
2013-03-28 |
2014-10-02 |
The Trustees Of Columbia University In The City Of New York |
Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
|
|
US20140287004A1
(en)
*
|
2005-11-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Use of an Omega-3 Lipid-Based Emulsion Following Ischemic Injury to Provide Protection and Recovery in Human Organs
|
|
US20070149617A1
(en)
*
|
2005-11-14 |
2007-06-28 |
Deckelbaum Richard J |
Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
|
|
WO2007061752A2
(en)
*
|
2005-11-17 |
2007-05-31 |
Bioavailability, Inc. |
Biocompatible latent emulsifiers
|
|
MY153288A
(en)
*
|
2006-06-28 |
2015-01-29 |
Hovid Berhad |
An effective pharmaceutical carrier for poorly bioavailable drugs
|
|
PT2068825E
(pt)
*
|
2006-10-04 |
2011-02-11 |
M & P Patent Ag |
Sistema de administração de libertação controlada para aplicação nasal de neurotransmissores
|
|
AU2008290536B2
(en)
*
|
2007-08-21 |
2012-02-09 |
Basilea Pharmaceutica Ag |
Antifungal composition
|
|
US20090130198A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
|
FR2925855B1
(fr)
*
|
2007-12-26 |
2010-11-05 |
Virbac Sa |
Composition liquide autoemulsionnable de florfenicol destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
|
|
CN110538148A
(zh)
*
|
2009-03-09 |
2019-12-06 |
巴斯夫股份公司 |
含有脂肪酸油混合物和表面活性剂的组合物及其方法和用途
|
|
JP2011006380A
(ja)
*
|
2009-05-22 |
2011-01-13 |
Mochida Pharmaceut Co Ltd |
ω３脂肪酸の乳化組成物
|
|
US8618168B2
(en)
*
|
2009-05-22 |
2013-12-31 |
Mochida Pharmaceutical Co., Ltd. |
Self-emulsifying composition of OMEGA3 fatty acid
|
|
WO2011047259A1
(en)
|
2009-10-16 |
2011-04-21 |
Glaxosmithkline Llc |
Compositions
|
|
WO2011048493A1
(en)
*
|
2009-10-23 |
2011-04-28 |
Pronova Biopharma Norge As |
Coated capsules and tablets of a fatty acid oil mixture
|
|
DK2366408T3
(da)
|
2010-03-01 |
2012-10-22 |
Salvat Lab Sa |
Vandige, klare opløsninger af fluocinolonacetonid til behandling af inflammation i øret
|
|
CA2798180A1
(en)
|
2010-05-03 |
2011-11-10 |
Teikoku Pharma Usa, Inc. |
Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
|
|
JP2013537185A
(ja)
*
|
2010-09-08 |
2013-09-30 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
遊離酸の形のｅｐａおよびｄｈａを含む脂肪酸油混合物と界面活性剤とスタチンとを含む組成物
|
|
KR20130103521A
(ko)
*
|
2010-09-08 |
2013-09-23 |
프로노바 바이오파마 너지 에이에스 |
지방산 오일 혼합물, 유리 지방산, 및 스타틴을 포함하는 조성물
|
|
AR082930A1
(es)
*
|
2010-09-08 |
2013-01-16 |
Pronova Biopharma Norge As |
Composiciones que comprenden una mezcla oleosa de acidos grasos, un tensioactivo y una estatina
|
|
JO3337B1
(ar)
*
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
JP6634034B2
(ja)
*
|
2014-06-25 |
2020-01-22 |
シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドＳｙｎｅｒｇｉａ Ｂｉｏ Ｓｃｉｅｎｃｅｓ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ |
医薬水中油型ナノエマルジョン
|
|
US11400048B2
(en)
|
2014-06-25 |
2022-08-02 |
Synergia Bio Sciences Private Limited |
Pharmaceutical oil-in-water nano-emulsion
|
|
EP3349717A4
(de)
|
2015-09-17 |
2019-04-17 |
JRX Biotechnology, Inc. |
Ansätze zur verbesserung der hauthydrierung oder -befeuchtung
|
|
WO2020053665A2
(en)
*
|
2018-09-13 |
2020-03-19 |
Ftf Pharma Private Limited |
Non-aqueous chemotherapeutic suspensions for oral dosage
|
|
US20200215027A1
(en)
*
|
2018-12-28 |
2020-07-09 |
Robert K. Prud'homme |
Dihydromyricetin nanoemulsion formulations and methods for forming them
|
|
US11465107B2
(en)
*
|
2019-01-31 |
2022-10-11 |
Hong Ngoc Thi Dang |
Process for producing a nano omega-3 microemulsion system
|
|
CZ309587B6
(cs)
*
|
2021-01-22 |
2023-05-03 |
Oncora S.R.O. |
Mikroemulzní prekoncentrát s obsahem kladribinu a způsob jeho přípravy
|